CP-463755

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCP-463755

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionProstaglandin E2 agonists

TargetsProstaglandin E2

Therapy Area/IndicationsFractures, Bone

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsFractures, Bone

Other Information

ATC CodeN/A

Related LinksN/A